Leipzig- Start of a new trial site

On the 6th May 2026, the University hospital Leipzig became officially another active trial site of the STOP-PKD Study.The team of  Dr. Friederike Petzold  cares for patients with a wide range of nephrological issues, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

Interested patients can now make an appointment at the trial site in Leipzig to obtain detailed information about the trail and potential participation.

Phone: +49 341 97 13180

Email: nephrologieambulanz@medizin.uni-leipzig.de